These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Efficacy and Safety of Individualized Coaching After Stroke: the LAST Study (Life After Stroke): A Pragmatic Randomized Controlled Trial. Askim T; Langhammer B; Ihle-Hansen H; Gunnes M; Lydersen S; Indredavik B; Stroke; 2018 Feb; 49(2):426-432. PubMed ID: 29284737 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of Intravenous Mesenchymal Stem Cells for Motor Recovery After Ischemic Stroke: A Neuroimaging Study. Lee J; Chang WH; Chung JW; Kim SJ; Kim SK; Lee JS; Sohn SI; Kim YH; Bang OY; Stroke; 2022 Jan; 53(1):20-28. PubMed ID: 34583525 [TBL] [Abstract][Full Text] [Related]
30. Mitoxantrone: a review of its use in multiple sclerosis. Scott LJ; Figgitt DP CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110 [TBL] [Abstract][Full Text] [Related]
31. Effect of Dextroamphetamine on Poststroke Motor Recovery: A Randomized Clinical Trial. Goldstein LB; Lennihan L; Rabadi MJ; Good DC; Reding MJ; Dromerick AW; Samsa GP; Pura J JAMA Neurol; 2018 Dec; 75(12):1494-1501. PubMed ID: 30167675 [TBL] [Abstract][Full Text] [Related]
32. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial. Álvaro-Gracia JM; Jover JA; García-Vicuña R; Carreño L; Alonso A; Marsal S; Blanco F; Martínez-Taboada VM; Taylor P; Martín-Martín C; DelaRosa O; Tagarro I; Díaz-González F Ann Rheum Dis; 2017 Jan; 76(1):196-202. PubMed ID: 27269294 [TBL] [Abstract][Full Text] [Related]
37. Allogeneic adipose tissue-derived mesenchymal stem cells in ischaemic stroke (AMASCIS-02): a phase IIb, multicentre, double-blind, placebo-controlled clinical trial protocol. de Celis-Ruiz E; Fuentes B; Moniche F; Montaner J; Borobia AM; Gutiérrez-Fernández M; Díez-Tejedor E BMJ Open; 2021 Aug; 11(8):e051790. PubMed ID: 34373315 [TBL] [Abstract][Full Text] [Related]
38. Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory Analysis. Sheth KN; Petersen NH; Cheung K; Elm JJ; Hinson HE; Molyneaux BJ; Beslow LA; Sze GK; Simard JM; Kimberly WT Stroke; 2018 Jun; 49(6):1457-1463. PubMed ID: 29789393 [TBL] [Abstract][Full Text] [Related]
39. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial. Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z; Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884 [TBL] [Abstract][Full Text] [Related]
40. Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study. Lublin FD; Bowen JD; Huddlestone J; Kremenchutzky M; Carpenter A; Corboy JR; Freedman MS; Krupp L; Paulo C; Hariri RJ; Fischkoff SA Mult Scler Relat Disord; 2014 Nov; 3(6):696-704. PubMed ID: 25891548 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]